feed,title,long_url,short_url
Benzinga,A Look Into Dixie Group's Price Over Earnings,https://benzinga.com/news/earnings/21/11/23991498/a-look-into-dixie-groups-price-over-earnings,https://j.mp/3BVoWP3
Benzinga,Price Over Earnings Overview: PGT Innovations,https://benzinga.com/news/earnings/21/11/23991492/price-over-earnings-overview-pgt-innovations,https://j.mp/3EZwcLN
Benzinga,S&W Seed's Debt Insights,https://benzinga.com/news/21/11/23991482/s-w-seeds-debt-insights,https://j.mp/3qmgYfH
Benzinga,"Takeda, Shattuck Labs Terminate Immuno-Oncology Pact",https://benzinga.com/general/biotech/21/11/23991438/takeda-shattuck-labs-terminate-immuno-oncology-pact,https://j.mp/3wzsNAj
Benzinga,Wireless Telecom Group's Debt Overview,https://benzinga.com/news/21/11/23991472/wireless-telecom-groups-debt-overview,https://j.mp/3ogVhei
Benzinga,Janssen Partially Terminates Nanoparticle License Agreement With Alkermes,https://benzinga.com/general/biotech/21/11/23989581/janssen-partially-terminates-nanoparticle-license-agreement-with-alkermes,https://j.mp/3EZLrUX
Benzinga,Immatics Unveils Early-Stage Data Of TCR-Engineered Cell Therapy In Solid Tumors,https://benzinga.com/general/biotech/21/11/23988442/immatics-unveils-early-stage-data-of-tcr-engineered-cell-therapy-in-solid-tumors,https://j.mp/30bUaog
Benzinga,Price Over Earnings Overview: Tapestry,https://benzinga.com/news/earnings/21/11/23991528/price-over-earnings-overview-tapestry,https://j.mp/3BY8OMP
Benzinga,Price Over Earnings Overview: Sally Beauty Holdings,https://benzinga.com/news/earnings/21/11/23991524/price-over-earnings-overview-sally-beauty-holdings,https://j.mp/30emLJM
Benzinga,US Regulators Balk at Billion-Dollar Takeover of Ports America,https://benzinga.com/government/21/11/23990601/us-regulators-balk-at-billion-dollar-takeover-of-ports-america,https://j.mp/2Yubynq
